InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Hu Zhaopeng, 管理人员. Director active across 2 companies, notably Ocumension Therapeutics - B. Cumulatively, 7 reports have been published. Regulator: HKEX. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Hu Zhaopeng is an executive at Ocumension Therapeutics - B, a company specializing in the development of innovative therapies. He oversees operations and contributes to the company's innovation strategy. His expertise is essential for Ocumension's success in the market.